U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07317440) titled 'Coenzyme Q10 in Pediatric Community-Acquired Pneumonia' on June 09, 2025.
Brief Summary: The aim of this work is to assess the benefit of coenzyme Q10 supplementation, in addition to standard antibiotic and other supportive therapy, in the management of hospitalized children with community acquired pneumonia
Study Start Date: Dec. 31, 2025
Study Type: INTERVENTIONAL
Condition:
Community Acquired Pneumonia
Intervention:
DRUG: oral coenzymeQ10
60 children with community acquired pneumonia will receive oral coenzymeQ10 in capsule form at a dose of 100-200 mg/kg/day, as adjunct therapy to the usual pneumonia treatment till the rec...